share_log

Community Health Sys Analyst Ratings

Benzinga ·  Oct 11, 2023 15:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/11/2023 25.22% Truist Securities $5 → $3.5 Maintains Hold
08/07/2023 132.56% Oppenheimer → $6.5 Reiterates Outperform → Outperform
06/20/2023 78.89% Truist Securities $4.5 → $5 Maintains Hold
05/03/2023 150.45% Citigroup $9 → $7 Maintains Buy
05/03/2023 150.45% RBC Capital $11 → $7 Maintains Outperform
05/03/2023 78.89% Wells Fargo $8 → $5 Maintains Equal-Weight
05/03/2023 164.76% Credit Suisse $8.5 → $7.4 Maintains Neutral
05/02/2023 132.56% Oppenheimer → $6.5 Reiterates → Outperform
02/17/2023 204.11% Credit Suisse $3.3 → $8.5 Maintains Neutral
01/19/2023 96.78% Oppenheimer $5 → $5.5 Maintains Outperform
01/03/2023 61% Wells Fargo $3 → $4.5 Maintains Equal-Weight
11/23/2022 18.07% Credit Suisse $4 → $3.3 Maintains Neutral
08/01/2022 132.56% Credit Suisse $8 → $6.5 Maintains Neutral
07/29/2022 114.67% Oppenheimer $16 → $6 Maintains Outperform
06/17/2022 78.89% Loop Capital → $5 Initiates Coverage On → Hold
06/15/2022 96.78% B of A Securities $7.5 → $5.5 Downgrades Buy → Neutral
05/02/2022 204.11% Wells Fargo $12 → $8.5 Maintains Equal-Weight
04/29/2022 400.89% Citigroup $18 → $14 Maintains Buy
04/29/2022 579.79% RBC Capital $21 → $19 Maintains Outperform
03/29/2022 329.34% Wells Fargo → $12 Initiates Coverage On → Equal-Weight
12/13/2021 472.45% B of A Securities $14 → $16 Upgrades Underperform → Buy
10/29/2021 418.78% Credit Suisse $12 → $14.5 Maintains Neutral
09/24/2021 347.23% UBS → $12.5 Initiates Coverage On → Neutral
08/03/2021 257.78% Barclays $6 → $10 Maintains Underweight
07/30/2021 329.34% Credit Suisse $10 → $12 Maintains Neutral
07/09/2021 Seaport Global Initiates Coverage On → Neutral
06/10/2021 651.34% RBC Capital $12 → $21 Upgrades Sector Perform → Outperform
05/05/2021 544.01% Jefferies $11 → $18 Upgrades Hold → Buy
04/30/2021 257.78% Credit Suisse $4.1 → $10 Upgrades Underperform → Neutral
02/19/2021 46.69% Credit Suisse $3.5 → $4.1 Maintains Underperform
05/04/2020 150.45% Oppenheimer $8 → $7 Maintains Outperform
02/20/2020 43.11% B of A Securities $3.5 → $4 Maintains Underperform
02/20/2020 Raymond James Upgrades Underperform → Market Perform
12/18/2019 25.22% SunTrust Robinson Humphrey $4 → $3.5 Maintains Hold
10/31/2018 43.11% Cantor Fitzgerald $6 → $4 Maintains Neutral

What is the target price for Community Health Sys (CYH)?

The latest price target for Community Health Sys (NYSE: CYH) was reported by Truist Securities on October 11, 2023. The analyst firm set a price target for $3.50 expecting CYH to rise to within 12 months (a possible 25.22% upside). 12 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Community Health Sys (CYH)?

The latest analyst rating for Community Health Sys (NYSE: CYH) was provided by Truist Securities, and Community Health Sys maintained their hold rating.

When is the next analyst rating going to be posted or updated for Community Health Sys (CYH)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Health Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Health Sys was filed on October 11, 2023 so you should expect the next rating to be made available sometime around October 11, 2024.

Is the Analyst Rating Community Health Sys (CYH) correct?

While ratings are subjective and will change, the latest Community Health Sys (CYH) rating was a maintained with a price target of $5.00 to $3.50. The current price Community Health Sys (CYH) is trading at is $2.80, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment